- Home
- / HCW Biologics
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
HCW Biologics financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0.4
2024-10-29
Market Capitalization
$16.7 M
2024-10-29
Revenue
$54.2 K
FY, 2025
CreditSafe Score
?
Score changed on Jun 11, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|
| Revenue | 6.7M | 2.8M | 2.6M | 54.2K | |
| Cost of goods sold | 4.1M | 2.3M | 1.6M | 43.4K | |
| Gross profit | 2.6M | 560.4K | 959.4K | 10.8K | |
| Gross profit margin, % | 38.6% | 37.4% | 20.0% | ||
| General and administrative expense | 5.2M | 8.3M | 13.4M | 6.8M | 7.7M |
| Operating expense total | 17.7M | 26.3M | 30.4M | 13.2M | |
| EBIT | (13.4M) | (15.1M) | (25.7M) | (29.5M) | (13.2M) |
| EBIT margin, % | -225.1% | -1148.5% | -24270.7% | ||
| Interest income | 505.4K | ||||
| Interest expense | 283.0K | 631.1K | |||
| Pre tax profit | (12.9M) | (14.9M) | (25.0M) | (30.0M) | (8.0M) |
| Net Income | (12.9M) | (14.9M) | (25.0M) | (30.0M) | (8.0M) |
| EPS | (0.4) | (0.8) | (10.6) |